Yokohama, Japan

Mayumi Tani

This inventor holds 1 USPTO granted patent. Top assignee: Mitsui Toatsu Chemicals, Incorporated. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayumi Tani. Retrieved from https://idiyas.com/inventor/mayumi-tani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mayumi Tani: Innovator in Chemical Engineering

Introduction

Mayumi Tani is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of chemical engineering, particularly in the development of innovative compounds. Her work has led to advancements that are beneficial in various industrial applications.

Latest Patents

Mayumi Tani holds a patent for a .beta.-amino-.beta.-propiolactam derivative and moisture curable. This invention showcases her expertise in creating novel chemical compounds that can be utilized in diverse applications.

Career Highlights

Tani is currently employed at Mitsui Toatsu Chemicals, Incorporated, where she continues to push the boundaries of chemical innovation. Her role at the company allows her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Masayuki Kamiyama and Kiyotsugu Asai. Their collective efforts contribute to the advancement of chemical technologies and innovations.

Conclusion

Mayumi Tani is a remarkable inventor whose work in chemical engineering has led to valuable patents and collaborations. Her contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…